mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1983 • 52,849 citations

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1984 • 6,841 citations

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

1993 • 1,047 citations

Differential Regulation of Retinoblastoma Tumor Suppressor Protein by G₁ Cyclin-Dependent Kinase Complexes In Vivo

2001 • 207 citations

The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL

2005 • 167 citations

Rapamycin is active against B-precursor leukemiain vitroandin vivo, an effect that is modulated by IL-7-mediated signaling

2003 • 158 citations

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells

2003 • 94 citations

Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?

2003 • 81 citations

Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia

2005 • 62 citations

The Molecular Mechanism of Resistance to Methotrexate in Mouse Methotrexate‐Resistant Cells by Cancer Drug Resistance and Metabolism SuperArray

2006 • 23 citations

mTOR inhibition leads to increased sensitivity to methotrexate

2005 • 5 citations

American Association for Cancer Research 98th Annual Meeting.

2007 • 1 citations